Serosurveillance of COVID-19 in Ireland Reports

A Prospective Study on the Prevalence of SARS-CoV-2 Antibodies among Children in Ireland, 2024

File Size: 500 KB
Publication Date: 20 January 2024

Correlation between a commercial SARS CoV 2 anti-spike RBD assay and neutralising antibody in the assessment of a functional antibody response in samples collected during a seroprevalence study in Ireland

File Size: 2.7 MB
Publication Date: 8 March 2024

Seroprevalence of SARS-CoV-2 antibodies in children

Publication Date: 28 September 2022

Seroprevalence of antibodies to SARS-CoV-2, Ireland: findings from blood donor residual sera surveillance 18 October 2021 – 14 January 2022

Publication Date: 14 April 2022

Seroprevalence of antibodies to SARS-CoV-2, Ireland: results from National Serosurveillance Programme(NSP) Pilot

Publication Date: December 2021

Seroprevalence of antibodies to SARS-CoV-2 in children aged 1-12 years and adults aged 18+ years: results from National Serosurveillance Programme Collection Cycle 1

Publication Date: 3 June 2022